Biodegradable macromers for the controlled release of biologically active substances
Patent 6153211 Issued on November 28, 2000. Estimated Expiration Date: July 17, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/426, Errodable, resorbable, or dissolving424/422, Implant or insert424/433, Depot, pellet, matrix, or suppository604/890.1, CONTROLLED RELEASE THERAPEUTIC DEVICE OR SYSTEM604/891.1Implanted dynamic device or system
A method for delivering a biologically active substance including the steps of: (a) combining said biologically active substance with a macromer; (b) forming a mixture of the combination formed in step (a); (c) polymerizing said mixture to form articles; and (d) administering said articles, or a portion thereof, to a mammal, where step (c) takes place in the absence of a polymerizable monovinyl monomer, is disclosed.
Other References
Clark et al., "Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol," The Journal of Biological Chemistry 271(36):21969-21977 (1996)
Cleland, "Protein Delivery from Biodegradable Microspheres," Pharmaceutical Biotechnology, Chapter 1, Protein Delivery Physical Systems (Sanders and Hendren, eds.) Plenum Press, New York pp. 1-43 (1997)
Gonda, "Aerosols for Delivery of Therapeutic and Diagnostic Agents to the Respiratory Tract," Critical Reviews in Therapeutic Drug Carrier Systems 6(4):273-313 (1990)
Hill-West et al., "Inhibition of thrombosis and intimal thickening by in situ photopolymerication of thin hydrogel barriers," Proc. Natl. Acad. Sci. 91:5967-5971 (1994)
Hubbell, "Hydrogel systems for barriers and local drug delivery in the control of wound healing," Journal of Controlled Release 39:305-313 (1996)
Hubbel, "Biomaterials in Tissue Engineering," Biotechnology 13:565-576 (1995)
Johnson et al., "A month-long effect from a single injection of microencapsulated human growth hormone," Nature Medicine 2(7):795-799 (1996)
Johnson et al., "The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres," Pharmaceutical Research 14(6):730-735 (1997)
Jørgensen et al., "Pulsatile Versus Continuous Intravenous Administration Growth Hormone (GH) in GH-Deficient Patients: Effects on Circulating Insulin-Like Growth Factor-I and Metabolic Indices," Journal of Clinical Endocrinology and Metabolism 70(6):1616-1623 (1990)
Krishnamurthy et al., "Stability of Proteins during Manufacture and Release from Biodegradable Polymers" BioPharm, pp. 32-35, Jan. 1998
Langer, "New Methods of Drug Delivery," Science 249:1527-1533 (1990)
Laursen et al., "Continuous Infusion Versus Daily Injections of Growth Hormone (GH) for 4 Weeks in GH-Deficient Patients," Journal of Clinical Endocrinology and Metabolism 80(8):2410-2417 (1995)
Lee et al., "In Vivo Characterization of Sustained-Release Formulations of Human Growth Hormone," The Journal of Pharmacology and Experimental Therapeutics 281(3):1431-1439 (1997)
Ron et al., "Controlled release of polypeptides from polyanhydrides," Proc. Natl. Acad. Sci. USA 90:4176-4180 (1993)
West et al., "Photopolymerized hydrogel materials for drug delivery applications," Reactive Polymers 25:139-147 (1995)
Sawhney et al., "Bioerodible Hydrogels Based on Photopolymerized Poly(ethylene glycol)-co-poly(-hydroxy acid) Diacrylate Macromers," Macromolecules 26(4):581-587 (1993
July 17, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
